The present invention relates to a method for diagnosing leukemia,
pre-leukemia or aleukemic malignant blood diseases, a method of
discriminating leukemia from pre-leukemia or aleukemic malignant blood
diseases, a method of discriminating aplastic anemia from myelodysplastic
syndrome, a method of diagnosing delayed engraftment of the hematopoietic
stem cells after transplantation of the hematopoietic stem cells, and a
method of diagnosing the graft versus host disease, each of said methods
comprising quantifying stem cell growth factor (SCGF). The present
invention also makes it possible to provide an agent for diagnosing
leukemia, pre-leukemia or aleukemic malignant blood diseases and an agent
for diagnosing delayed engraftment of the hematopoietic stem cells after
transplantation of the hematopoietic stem cells or an agent for
diagnosing graft versus host disease (GVHD), each containing as an active
ingredient an antibody reacting with stem cell growth factor (SCGF).